Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without down syndrome

M. D. Brissette, B. J. Duval-Arnould, Bruce Geoffrey Gordon, J. D. Cotelingam

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Transient myeloproliferative disorder (TMD) and subsequent acute myeloid leukemia (AML) occur with increased frequency in infants and children with Down syndrome. TMD can also occur in phenotypically normal newborns. We describe the second case of a non‐Down syndrome child with TMD who subsequently developed AML. Trisomy 21 karyotype was restricted to hematopoietic cells in the blood and bone marrow. No other karyotypic abnormalities were found. Leukemic blasts showed megakaryoblastic features with immunophenotyping. This case shows that TMD in a child without Down syndrome may not be entirely benign. Close follow‐up is warranted. © 1994 Wiley‐Liss, Inc.

Original languageEnglish (US)
Pages (from-to)316-319
Number of pages4
JournalAmerican Journal of Hematology
Volume47
Issue number4
DOIs
StatePublished - Jan 1 1994

Fingerprint

Leukemia, Megakaryoblastic, Acute
Myeloproliferative Disorders
Down Syndrome
Acute Myeloid Leukemia
Immunophenotyping
Karyotype
Blood Cells
Bone Marrow
Newborn Infant

Keywords

  • acute leukemia
  • transient myeloproliferative disorder
  • trisomy 21

ASJC Scopus subject areas

  • Hematology

Cite this

Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without down syndrome. / Brissette, M. D.; Duval-Arnould, B. J.; Gordon, Bruce Geoffrey; Cotelingam, J. D.

In: American Journal of Hematology, Vol. 47, No. 4, 01.01.1994, p. 316-319.

Research output: Contribution to journalArticle

@article{f33539aacf674a9d8140b24f75053bc5,
title = "Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without down syndrome",
abstract = "Transient myeloproliferative disorder (TMD) and subsequent acute myeloid leukemia (AML) occur with increased frequency in infants and children with Down syndrome. TMD can also occur in phenotypically normal newborns. We describe the second case of a non‐Down syndrome child with TMD who subsequently developed AML. Trisomy 21 karyotype was restricted to hematopoietic cells in the blood and bone marrow. No other karyotypic abnormalities were found. Leukemic blasts showed megakaryoblastic features with immunophenotyping. This case shows that TMD in a child without Down syndrome may not be entirely benign. Close follow‐up is warranted. {\circledC} 1994 Wiley‐Liss, Inc.",
keywords = "acute leukemia, transient myeloproliferative disorder, trisomy 21",
author = "Brissette, {M. D.} and Duval-Arnould, {B. J.} and Gordon, {Bruce Geoffrey} and Cotelingam, {J. D.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1002/ajh.2830470413",
language = "English (US)",
volume = "47",
pages = "316--319",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without down syndrome

AU - Brissette, M. D.

AU - Duval-Arnould, B. J.

AU - Gordon, Bruce Geoffrey

AU - Cotelingam, J. D.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Transient myeloproliferative disorder (TMD) and subsequent acute myeloid leukemia (AML) occur with increased frequency in infants and children with Down syndrome. TMD can also occur in phenotypically normal newborns. We describe the second case of a non‐Down syndrome child with TMD who subsequently developed AML. Trisomy 21 karyotype was restricted to hematopoietic cells in the blood and bone marrow. No other karyotypic abnormalities were found. Leukemic blasts showed megakaryoblastic features with immunophenotyping. This case shows that TMD in a child without Down syndrome may not be entirely benign. Close follow‐up is warranted. © 1994 Wiley‐Liss, Inc.

AB - Transient myeloproliferative disorder (TMD) and subsequent acute myeloid leukemia (AML) occur with increased frequency in infants and children with Down syndrome. TMD can also occur in phenotypically normal newborns. We describe the second case of a non‐Down syndrome child with TMD who subsequently developed AML. Trisomy 21 karyotype was restricted to hematopoietic cells in the blood and bone marrow. No other karyotypic abnormalities were found. Leukemic blasts showed megakaryoblastic features with immunophenotyping. This case shows that TMD in a child without Down syndrome may not be entirely benign. Close follow‐up is warranted. © 1994 Wiley‐Liss, Inc.

KW - acute leukemia

KW - transient myeloproliferative disorder

KW - trisomy 21

UR - http://www.scopus.com/inward/record.url?scp=0028088657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028088657&partnerID=8YFLogxK

U2 - 10.1002/ajh.2830470413

DO - 10.1002/ajh.2830470413

M3 - Article

VL - 47

SP - 316

EP - 319

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -